Logo

Labcyte Signs up Singapore, Korean Distributors

Jul 21, 2009

NEW YORK (GenomeWeb News) – Labcyte said today that it has signed up Bio Laboratories and Chayon Laboratories to distribute its low-volume liquid transfer technologies in Singapore and Korea, respectively.

Both distributors will market Labcyte’s Deerac and Echo instruments, which use sound to move liquids for applications in the genomics, proteomics, and live-cell transfer fields.

Stephen Bates, Labcyte’s VP of sales and marketing and service, said that the agreements are directed toward the “growing genomics markets, especially for gene expression, SNP analysis, and RNAi.”

Labcyte is based in Sunnyvale, Calif., and it has an office in Dublin, Ireland.

Filed under

liquid handling
Labcyte
Breaking News
The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.